Stein Robert Benjamin - 13 Mar 2023 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)

Reporting relationship: President, Regenerative Med.
Issuer ticker: MDXG
Reported as of: 13 Mar 2023
Net transaction value: +$624,000
SEC form: 4
Accepted by SEC: 15 Mar 2023, 18:26:52 UTC
Prior SEC filing: 09 Mar 2023
Next SEC filing: 13 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/ William F. Hulse as attorney in fact for Robert Benjamin Stein

Key filing fact

Stein Robert Benjamin filed Form 4 for MIMEDX GROUP, INC. (MDXG) on 15 Mar 2023.

Key facts

This page summarizes Stein Robert Benjamin's Form 4 filing for MIMEDX GROUP, INC. (MDXG).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Mar 2023, 18:26.

Change

Previous filing in this sequence was filed on 09 Mar 2023.
Current net transaction value: +$624,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDXG transaction

Common Stock

Award

Transaction value: $624,000
Shares: +135,065
Change %: +51%
Price: $4.62
Shares after: 401,383
Date: 13 Mar 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3.